Cargando…
Peptide–drug conjugates (PDCs): a novel trend of research and development on targeted therapy, hype or hope?
Peptide–drug conjugates (PDCs) are the next generation of targeted therapeutics drug after antibody–drug conjugates (ADCs), with the core benefits of enhanced cellular permeability and improved drug selectivity. Two drugs are now approved for market by US Food and Drug Administration (FDA), and in t...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9978859/ https://www.ncbi.nlm.nih.gov/pubmed/36873165 http://dx.doi.org/10.1016/j.apsb.2022.07.020 |